|
SLC25A24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.09490000000678E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07509999999855E-05 |
| Normal-vs-Stage2 |
3.192300E-02 |
| Normal-vs-Stage3 |
2.206400E-01 |
| Normal-vs-Stage4 |
1.335600E-01 |
| Stage1-vs-Stage2 |
6.600000E-01 |
| Stage1-vs-Stage3 |
2.645600E-01 |
| Stage1-vs-Stage4 |
8.836200E-01 |
| Stage2-vs-Stage3 |
6.535800E-01 |
| Stage2-vs-Stage4 |
8.637800E-01 |
| Stage3-vs-Stage4 |
6.401400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.95960000000306E-05 |
| Normal-vs-AfricanAmerican |
1.766190E-04 |
| Normal-vs-Asian |
8.194600E-01 |
| Caucasian-vs-AfricanAmerican |
5.018400E-01 |
| Caucasian-vs-Asian |
4.017600E-01 |
| AfricanAmerican-vs-Asian |
2.911200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.30259999640148E-08 |
| Normal-vs-Female |
8.517000E-01 |
| Male-vs-Female |
4.600600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.862600E-03 |
| Normal-vs-Extreme_Weight |
3.8780000000127E-07 |
| Normal-vs-Obese |
8.541100E-03 |
| Normal-vs-Extreme_Obese |
3.109700E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.509400E-01 |
| Normal_Weight-vs-Obese |
5.227400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.222400E-01 |
| Extreme_Weight-vs-Obese |
9.965600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.795400E-01 |
| Obese-vs-Extreme_Obese |
4.536600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.909200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.015800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.84819999998953E-06 |
| Normal-vs-Age(81-100Yrs) |
4.139100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.780400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.048200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.181450E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.239400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.783230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.086600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.14780000007408E-07 |
| Normal-VS-Type2 PRCC |
4.098100E-03 |
| Normal-VS-KIRP CIMP |
3.553400E-01 |
| Normal-VS-Unclassified PRCC |
3.994400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.088200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.763700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.456000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.674340E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.248400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.161970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.24319999999812E-05 |
| Normal-vs-N1 |
5.493200E-01 |
| Normal-vs-N2 |
5.472200E-01 |
| N0-vs-N1 |
9.544100E-02 |
| N0-vs-N2 |
5.953200E-01 |
| N1-vs-N2 |
7.256800E-01 |
|
|
